Life Sciences

Finding sustainability in biotechnology, pharmaceutical and medical technology

Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

We cover key issues in these areas:




    Contact us

    Jon Junyoung Huh
    Life sciences
    Assurance, Partner
    Tel: +82 2 3787 6378

    Connect with us

    Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

    Disruptors: Revolutionizing Drug/Dx Reimbursement

    1-2 November 2012
    Philadelphia, Pennsylvania (US)
    Presented by EY and Real Endpoints

    Join us at this premier event which brings together senior executives from leading product (pharma, medtech, biotech) companies along with payers, providers and policymakers to discuss the key issues that will set the product reimbursement agenda over the next few years.

    Infographic: Turning the tide on cancer drug costs

    EY - Infographic: Turning the tide on cancer drug costs